Together, these findings establish for the first time a condition-dependent two-way regulation based on miRNA-RBP interaction and provide a proof-of-principle rationale for developing miRNA-based, hnRNP L-targeted therapeutic strategies against cancer [51], [52]. Here, HNRNPL is linked to cancer.